<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>23</Volume><Issue>8</Issue><PubDate PubStatus="epublish"><Year>2018</Year><Month>08</Month><Day>25</Day></PubDate></Journal><title locale="en_US">Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices</title><FirstPage>10827</FirstPage><LastPage>10827</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2018</Year><Month>08</Month><Day>20</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Tis study aimed to assess the serum serotonin levels in the newly diagnosed fbromyalgia (FM) and to relate these levels to the presenting signs and symptoms. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Tis case–control study included 35 healthy women (Group I) served  as controls and 130 women with newly diagnosed FM (Group II). Te diagnosis of FM was confrmed by the diagnostic criteria of the American College of Rheumatology?10. Te assessment of pain using a revised fbromyalgia impact questionnaire and tender points scoring, blood platelet indices, and serum serotonin levels were determined. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Group II patients had signifcantly (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001) higher values of mean platelet volume (MPV) (10.60 ± 1.57fL) and platelet width distribution (16.25 ± 1.45%) than the corresponding values in Group I (8.73 ± 0.81fL and 15.0 ± 1.15%). Signifcant low?serum serotonin levels observed in Group II patients compared with Group I healthy individuals (187.3 ± 50.3 ng/ml vs. 219.5 ± 78.3 ng/ml, &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.026). Multiple linear regression analysis showed the&lt;br /&gt;nonsignifcant correlations between serum serotonin levels and platelet indices in Group II patients. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Newly diagnosed FM women have signifcantly low?serum serotonin levels, which does not correlate with a signifcant increment of the platelet activity expressed as increase MPV and platelet width distribution percentage. Terefore, this study highlighted that the correction of serum serotonin level by medicines could help the patients.&lt;br /&gt;&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10827</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10827/5662</pdf_url></Article></Articles>
